In Focus

Red Dab? Red Flag

Helping Black women spot endometrial cancer symptoms

Learn more

Close Video

Best Place to Work for Disability Inclusion

We have pledged to remove barriers and limitations for everyone at GSK.

Creating a culture where individuals and teams thrive

Visit "At a glance" for details about our US operations

Jigar smiling in a black shirt as the headline to the leading the way to inclusion story

Leading the way to inclusion: Jigar's story

Jigar may not have intended to serve as a role model, but he knows it's what's needed

Meet our outstanding people

Visit our global site to learn how our people are using their talents to work and innovate together

Employee resource groups (ERG) in action

During Pride month, we are shining the spotlight on our LGBTQ+ ERG, Spectrum

Investors

We have announced our second quarter 2022 results.

Visit our global website for latest results

View all press releases

Three people seated around a table with laptops

GSKUS on twitter

#DYK that #MultipleMyeloma is the second most common blood cancer in the U.S.? In honor of #BloodCancerAwarenessMonth, test your knowledge of this disease below👇 How many cases of Multiple Myeloma are estimated to be diagnosed in 2022?

Twitter @GSKUS
PODCAST ALERT 🔊: Listen as our Head of Patient Services talks with@lifelnksystemss about how innovation and mobile technology can help patients on their medication journeys and contribute to the broader health equity challenge.gsk.to/3fstRBqo

Twitter @GSKUS
Last week we were at #ClimateWeekNYC. We announced two new projects and shared our lessons learnt so far to help deliver a healthy planet for healthy people. Now’s the time to put health at the centre of the climate and nature conversations at #COP27 and #COP15. #AheadTogether

Twitter @GSKUS
We are pleased to share in the spirit of supporting the communities where we live and work, that we are providing funding to support #HurricaneFiona relief and recovery efforts in Puerto Rico. Learn more: gsk.to/3BZvHSj

Twitter @GSKUS
Today, Sept. 23rd at 12pm ET, join Judy Stewart, our Head of #Vaccines & Dr. Kelly Moore, Head of @ImmunizeOrg, on @PostLive as they discuss #data transparency & addressing gaps in adult #vaccination rates. Register: bit.ly/3xCBICZ. #PostLive #PublicHealth

Twitter @GSKUS
Join Lamont at @NOBCChE Global Science Awakening Sept 26-29 in Orlando. Stop by our booth for exciting career opportunities in #chemistry, #drugdiscovery & #innovation. Conference: nobcche.org/conference GSK careers: us.gsk.com/en-us/careers/ #NOBCChE #GSKChemistry

Twitter @GSKUS
#News for #Investors and #Media Today we entered into an exclusive license agreement with Spero Therapeutics. This builds on our commitment to grow our late-stage pipeline of new medicines and vaccines to help get ahead of infectious diseases. ms.spr.ly/6019jA8gl

Twitter @GSKUS
70% of women with advanced disease experience a relapse within 2 years of initial treatment , but maintenance therapy may help extend the time before the cancer comes back. Watch the below video & learn more at: bit.ly/3MYZiOR. #OvarianCancerAwarenessMonth

Twitter @GSKUS
Two years on from setting our goals for a #netzero impact on #climate and a net positive impact on #nature for a healthier planet, we’ve made good progress. We’re sharing our top 5 learnings to help others tackling these shared challenges. #GettingItDone

Twitter @GSKUS
Join our Chief Procurement Officer Lisa Martin at 1:30pm EST when she’ll be talking about our new sustainable procurement programme during a #ClimateWeekNYC panel on supply chain emission reductions. Register here: gsk.to/3eWCqnU

Twitter @GSKUS